CVS faces strong competition from Amazon, Walmart, and Costco, impacting market share. Read why I maintain a Hold rating for ...

The U.S. government on Friday proposed 2026 reimbursement rates for Medicare Advantage plans run by private insurers that ...

Bullish option flow detected in CVS Health (CVS) with 33,211 calls trading, 1.7x expected, and implied vol increasing over 7 points to 47.44%.

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Out of all of the special options we uncovered, 6 are puts, for a total amount of $241,558, and 4 are calls, for a total ...

CVS Health CVS shareholders are experiencing a rough period as the stock continues to face significant downward pressure. Recent reports about the company's strategic restructuring plans have ...

CVS' Aetna sues drug manufacturers for price-fixing and market allocation scheme. The subsidiary seeks damages and ...

CVS Caremark will add Zydus' ZituvioTM and combination products to its template formulary starting January 1, 2025 ...

Evercore ISI analyst Elizabeth Anderson CFA maintained a Buy rating on CVS Health (CVS – Research Report) today and set a price target of ...

CVS Health Corp. shares dipped below $50 on Thursday ... Separately, PBMs are being sued by the Federal Trade Commission. The industry is pushing back, saying the lawsuits are without merit ...

Innovative approach uses a transparent formula built on the drug acquisition cost, a set markup, and a fee to reflect the quality of pharmacy services provided New reimbursement model supports ...